vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and C & F FINANCIAL CORP (CFFI). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $35.9M, roughly 1.2× C & F FINANCIAL CORP). C & F FINANCIAL CORP runs the higher net margin — 18.7% vs -19.9%, a 38.6% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 12.0%). C & F FINANCIAL CORP produced more free cash flow last quarter ($22.2M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 8.2%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Sun Life Financial Inc. is a Canadian financial services company headquartered in Toronto, Ontario. Founded in 1865, it operates internationally in life insurance, wealth management, and asset management. As of 2024, the company manages over CAD$1.3 trillion in assets and serves clients in Canada, the United States, Asia, and other markets.
ABCL vs CFFI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $35.9M |
| Net Profit | $-8.9M | $6.7M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 22.6% |
| Net Margin | -19.9% | 18.7% |
| Revenue YoY | 788.4% | 12.0% |
| Net Profit YoY | 73.9% | 11.0% |
| EPS (diluted) | $-0.03 | $2.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $35.9M | ||
| Q3 25 | $9.0M | $36.0M | ||
| Q2 25 | $17.1M | $36.4M | ||
| Q1 25 | $4.2M | $32.6M | ||
| Q4 24 | $5.0M | $32.0M | ||
| Q3 24 | $6.5M | $33.5M | ||
| Q2 24 | $7.3M | $31.2M | ||
| Q1 24 | $10.0M | $30.6M |
| Q4 25 | $-8.9M | $6.7M | ||
| Q3 25 | $-57.1M | $7.1M | ||
| Q2 25 | $-34.7M | $7.7M | ||
| Q1 25 | $-45.6M | $5.4M | ||
| Q4 24 | — | $6.0M | ||
| Q3 24 | $-51.1M | $5.4M | ||
| Q2 24 | $-36.9M | $5.0M | ||
| Q1 24 | $-40.6M | $3.4M |
| Q4 25 | -63.7% | 22.6% | ||
| Q3 25 | -851.8% | 24.5% | ||
| Q2 25 | -290.2% | 26.5% | ||
| Q1 25 | -1479.6% | 20.0% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | -1439.4% | 19.9% | ||
| Q2 24 | -1276.2% | 20.0% | ||
| Q1 24 | -551.5% | 13.1% |
| Q4 25 | -19.9% | 18.7% | ||
| Q3 25 | -637.8% | 19.6% | ||
| Q2 25 | -203.3% | 21.2% | ||
| Q1 25 | -1077.2% | 16.5% | ||
| Q4 24 | — | 18.8% | ||
| Q3 24 | -785.4% | 16.1% | ||
| Q2 24 | -504.3% | 16.1% | ||
| Q1 24 | -408.0% | 11.1% |
| Q4 25 | $-0.03 | $2.08 | ||
| Q3 25 | $-0.19 | $2.18 | ||
| Q2 25 | $-0.12 | $2.37 | ||
| Q1 25 | $-0.15 | $1.66 | ||
| Q4 24 | — | $1.85 | ||
| Q3 24 | $-0.17 | $1.65 | ||
| Q2 24 | $-0.13 | $1.50 | ||
| Q1 24 | $-0.14 | $1.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $261.8M |
| Total Assets | $1.4B | $2.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — | ||
| Q1 24 | $123.6M | — |
| Q4 25 | $966.9M | $261.8M | ||
| Q3 25 | $964.0M | $253.3M | ||
| Q2 25 | $1.0B | $240.3M | ||
| Q1 25 | $1.0B | $234.6M | ||
| Q4 24 | $1.1B | $226.4M | ||
| Q3 24 | $1.1B | $227.3M | ||
| Q2 24 | $1.1B | $218.5M | ||
| Q1 24 | $1.1B | $216.3M |
| Q4 25 | $1.4B | $2.8B | ||
| Q3 25 | $1.4B | $2.7B | ||
| Q2 25 | $1.4B | $2.7B | ||
| Q1 25 | $1.3B | $2.6B | ||
| Q4 24 | $1.4B | $2.6B | ||
| Q3 24 | $1.4B | $2.6B | ||
| Q2 24 | $1.4B | $2.5B | ||
| Q1 24 | $1.5B | $2.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $24.5M |
| Free Cash FlowOCF − Capex | $-44.6M | $22.2M |
| FCF MarginFCF / Revenue | -99.4% | 61.8% |
| Capex IntensityCapex / Revenue | 21.9% | 6.5% |
| Cash ConversionOCF / Net Profit | — | 3.65× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $42.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $24.5M | ||
| Q3 25 | $-52.6M | $23.4M | ||
| Q2 25 | $-32.4M | $-4.4M | ||
| Q1 25 | $-11.6M | $3.2M | ||
| Q4 24 | $-108.6M | $36.8M | ||
| Q3 24 | $-28.9M | $404.0K | ||
| Q2 24 | $-30.0M | $1.7M | ||
| Q1 24 | $-41.7M | $895.0K |
| Q4 25 | $-44.6M | $22.2M | ||
| Q3 25 | $-61.5M | $22.7M | ||
| Q2 25 | $-45.8M | $-5.0M | ||
| Q1 25 | $-22.2M | $2.9M | ||
| Q4 24 | $-187.0M | $33.3M | ||
| Q3 24 | $-47.4M | $-1.6M | ||
| Q2 24 | $-50.1M | $1.2M | ||
| Q1 24 | $-65.8M | $410.0K |
| Q4 25 | -99.4% | 61.8% | ||
| Q3 25 | -687.0% | 63.0% | ||
| Q2 25 | -267.9% | -13.6% | ||
| Q1 25 | -524.0% | 9.0% | ||
| Q4 24 | -3702.8% | 103.8% | ||
| Q3 24 | -728.4% | -4.9% | ||
| Q2 24 | -683.8% | 3.7% | ||
| Q1 24 | -661.5% | 1.3% |
| Q4 25 | 21.9% | 6.5% | ||
| Q3 25 | 99.7% | 2.1% | ||
| Q2 25 | 78.2% | 1.6% | ||
| Q1 25 | 251.1% | 0.8% | ||
| Q4 24 | 1552.7% | 10.9% | ||
| Q3 24 | 284.6% | 6.1% | ||
| Q2 24 | 274.6% | 1.7% | ||
| Q1 24 | 242.5% | 1.6% |
| Q4 25 | — | 3.65× | ||
| Q3 25 | — | 3.31× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 0.60× | ||
| Q4 24 | — | 6.09× | ||
| Q3 24 | — | 0.07× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
CFFI
| Community Banking | $25.9M | 72% |
| Consumer Finance Segment | $7.0M | 19% |
| Mortgage Banking Segment | $1.9M | 5% |
| Other | $1.1M | 3% |
